Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Medical University of South Carolina

Medical University of South Carolina in Charleston, South Carolina, United States is listed as a site for 2,471 registered clinical trials, 690 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 2,471
Ongoing 690

This page covers the site record Medical University of South Carolina in Charleston, South Carolina, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Medical University of South Carolina, also sponsors trials.

Get the Medical University of South Carolina report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 2,471 trials counted.

  • Phase 1 139 trials
  • Phase 1/2 93 trials
  • Phase 2 552 trials
  • Phase 2/3 68 trials
  • Phase 3 593 trials
  • Phase 4 78 trials
  • Not applicable 625 trials
  • Observational 317 trials
  • Expanded access 5 trials
  • Unknown 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 691 trials
  • Completed 1,429 trials
  • Terminated 297 trials
  • Other 54 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Unknown)

Top of scale: 141

1992: 4 trials (Observational 2, Phase 3 1, Phase 2 1) 1993: 1 trials (Phase 2 1) 1994: 12 trials (Phase 3 9, Phase 2 2, Phase 1/2 1) 1995: 3 trials (Phase 3 2, Phase 1/2 1) 1996: 6 trials (Phase 3 5, Phase 2 1) 1997: 22 trials (Observational 2, Phase 3 10, Phase 2 5, Phase 1/2 3, Phase 1 2) 1998: 38 trials (Observational 3, Not applicable 1, Phase 3 9, Phase 2 16, Phase 1/2 1, Phase 1 8) 1999: 24 trials (Observational 3, Not applicable 3, Phase 4 1, Phase 3 5, Phase 2 10, Phase 1 2) 2000: 35 trials (Observational 1, Not applicable 2, Phase 4 1, Phase 3 9, Phase 2 18, Phase 1 4) 2001: 26 trials (Observational 1, Not applicable 1, Phase 4 2, Phase 3 5, Phase 2/3 1, Phase 2 15, Phase 1 1) 2002: 15 trials (Phase 3 6, Phase 2 6, Phase 1/2 1, Phase 1 2) 2003: 25 trials (Observational 3, Not applicable 3, Phase 4 2, Phase 3 9, Phase 2 6, Phase 1 2) 2004: 31 trials (Observational 3, Not applicable 2, Phase 4 1, Phase 3 14, Phase 2/3 1, Phase 2 7, Phase 1/2 1, Phase 1 2) 2005: 32 trials (Observational 3, Not applicable 7, Phase 4 1, Phase 3 13, Phase 2/3 1, Phase 2 4, Phase 1/2 3) 2006: 66 trials (Observational 13, Not applicable 7, Phase 4 3, Phase 3 32, Phase 2 8, Phase 1/2 1, Phase 1 2) 2007: 66 trials (Other 1, Observational 9, Not applicable 11, Phase 4 6, Phase 3 23, Phase 2/3 5, Phase 2 10, Phase 1/2 1) 2008: 59 trials (Observational 11, Not applicable 9, Phase 4 2, Phase 3 14, Phase 2 18, Phase 1/2 5) 2009: 70 trials (Observational 10, Not applicable 14, Phase 4 3, Phase 3 25, Phase 2 14, Phase 1/2 2, Phase 1 2) 2010: 85 trials (Observational 12, Not applicable 13, Phase 4 6, Phase 3 24, Phase 2/3 1, Phase 2 22, Phase 1/2 4, Phase 1 3) 2011: 86 trials (Observational 13, Not applicable 23, Phase 4 3, Phase 3 17, Phase 2/3 2, Phase 2 18, Phase 1/2 4, Phase 1 6) 2012: 87 trials (Observational 17, Not applicable 22, Phase 3 16, Phase 2/3 1, Phase 2 23, Phase 1/2 4, Phase 1 4) 2013: 102 trials (Observational 11, Not applicable 32, Phase 4 4, Phase 3 15, Phase 2/3 5, Phase 2 23, Phase 1/2 1, Phase 1 11) 2014: 104 trials (Observational 19, Not applicable 31, Phase 4 2, Phase 3 16, Phase 2/3 5, Phase 2 19, Phase 1/2 4, Phase 1 8) 2015: 115 trials (Observational 16, Not applicable 29, Phase 4 5, Phase 3 26, Phase 2/3 3, Phase 2 27, Phase 1/2 3, Phase 1 6) 2016: 116 trials (Observational 13, Not applicable 27, Phase 4 7, Phase 3 21, Phase 2/3 3, Phase 2 33, Phase 1/2 5, Phase 1 7) 2017: 139 trials (Observational 19, Not applicable 27, Phase 4 2, Phase 3 30, Phase 2/3 4, Phase 2 43, Phase 1/2 5, Phase 1 9) 2018: 130 trials (Observational 17, Not applicable 38, Phase 4 2, Phase 3 30, Phase 2/3 2, Phase 2 28, Phase 1/2 4, Phase 1 9) 2019: 125 trials (Observational 12, Not applicable 38, Phase 4 2, Phase 3 27, Phase 2/3 6, Phase 2 29, Phase 1/2 8, Phase 1 3) 2020: 127 trials (Observational 19, Not applicable 43, Phase 4 3, Phase 3 22, Phase 2/3 2, Phase 2 24, Phase 1/2 5, Phase 1 9) 2021: 126 trials (Observational 18, Not applicable 38, Phase 4 2, Phase 3 30, Phase 2/3 6, Phase 2 19, Phase 1/2 5, Phase 1 8) 2022: 141 trials (Observational 18, Not applicable 39, Phase 4 8, Phase 3 22, Phase 2/3 9, Phase 2 33, Phase 1/2 8, Phase 1 4) 2023: 120 trials (Observational 13, Not applicable 39, Phase 4 3, Phase 3 37, Phase 2/3 5, Phase 2 16, Phase 1/2 3, Phase 1 4) 2024: 125 trials (Observational 16, Not applicable 48, Phase 4 3, Phase 3 20, Phase 2/3 4, Phase 2 20, Phase 1/2 6, Phase 1 8) 2025: 112 trials (Observational 15, Not applicable 33, Phase 4 2, Phase 3 39, Phase 2/3 1, Phase 2 15, Phase 1 7)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 79
2025 112
2024 125
2023 120
2022 141
2021 126
2020 127
2019 125
2018 130
2017 139

2026 is partial: trials registered with a 2026 start date so far, not a full year. 4 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Conditions studied

The specific conditions of the trials that list this site, most trials first.